We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+71.21%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$491M
AUM Growth
+$188M
Cap. Flow
+$45.5M
Cap. Flow %
9.28%
Top 10 Hldgs %
18.99%
Holding
156
New
44
Increased
44
Reduced
29
Closed
39

Top Buys

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$7.26M
2
OLLI icon
Ollie's Bargain Outlet
OLLI
+$6.35M
3
CDNA icon
CareDx
CDNA
+$6.35M
4
NET icon
Cloudflare
NET
+$5.7M
5
LSCC icon
Lattice Semiconductor
LSCC
+$5.59M

Top Sells

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$9.22M
2
FCN icon
FTI Consulting
FCN
+$6.26M
3
ITRI icon
Itron
ITRI
+$6.25M
4
RGEN icon
Repligen
RGEN
+$6.07M
5
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
+$5.44M

Sector Composition

Rank Sector Weight
1 Healthcare 23.1%
2 Technology 22.24%
3 Industrials 19.83%
4 Consumer Discretionary 16.89%
5 Financials 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSM icon
76
Williams-Sonoma
WSM
$26B
$2.94M 0.6%
+71,770
New +$2.44M
UPLD icon
77
Upland Software
UPLD
$12.3M
$2.92M 0.6%
+8,415
New +$2.62M
POWI icon
78
Power Integrations
POWI
$2.66B
$2.86M 0.58%
+48,400
New +$2.54M
COHR icon
79
Coherent
COHR
$56.6B
$2.76M 0.56%
+58,470
New +$2.32M
PRLB icon
80
Protolabs
PRLB
$1.98B
$2.61M 0.53%
+23,185
New +$2.38M
ALK icon
81
Alaska Air
ALK
$4.45B
$2.42M 0.49%
66,660
+35,520
+114% +$1.16M
DCPH
82
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.36M 0.48%
39,530
+21,040
+114% +$1.13M
PEN icon
83
Penumbra
PEN
$12.6B
$2.22M 0.45%
12,405
-2,622
-17% -$455K
ENTG icon
84
Entegris
ENTG
$20B
$2.12M 0.43%
35,820
-705
-2% -$39.2K
IRTC icon
85
iRhythm Holdings
IRTC
$3.76B
$2.07M 0.42%
+17,835
New +$1.97M
VRM icon
86
Vroom Inc
VRM
$53.1M
$2.03M 0.41%
+488
New +$1.89M
NBIX icon
87
Neurocrine Biosciences
NBIX
$15.3B
$1.87M 0.38%
15,315
+5,620
+58% +$621K
PAYC icon
88
Paycom
PAYC
$10.3B
$1.85M 0.38%
5,970
+2,938
+97% +$782K
MASI
89
DELISTED
Masimo
MASI
$1.85M 0.38%
8,095
-7,841
-49% -$1.72M
HUBS icon
90
HubSpot
HUBS
$11.9B
$1.84M 0.38%
8,205
-9,995
-55% -$1.8M
VEEV icon
91
Veeva Systems
VEEV
$43.3B
$1.84M 0.37%
+7,840
New +$1.55M
JBLU icon
92
JetBlue
JBLU
$1.63B
$1.84M 0.37%
168,410
+64,215
+62% +$632K
SRPT icon
93
Sarepta Therapeutics
SRPT
$2.13B
$1.83M 0.37%
11,400
+4,868
+75% +$662K
BC icon
94
Brunswick
BC
$4.5B
$1.71M 0.35%
26,680
+11,440
+75% +$570K
PI icon
95
Impinj
PI
$5.47B
$1.62M 0.33%
+58,955
New +$1.38M
ZS icon
96
Zscaler
ZS
$31.8B
$1.56M 0.32%
14,265
+5,075
+55% +$422K
AIT icon
97
Applied Industrial Technologies
AIT
$11.6B
$1.55M 0.32%
24,875
-38,010
-60% -$2.07M
PTON icon
98
Peloton Interactive
PTON
$2.12B
$1.55M 0.32%
26,845
-7,470
-22% -$309K
TECH icon
99
Bio-Techne
TECH
$11.3B
$1.54M 0.31%
+23,260
New +$1.39M
BYND icon
100
Beyond Meat
BYND
$191M
$1.41M 0.29%
+351
New +$1.25M
2 3
4
5 6

Similar funds

HFA
Highland Financial Advisors Wayne, New Jersey $455M AUM 22.51% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return
PIM
Progressive Investment Management Lake Oswego, Oregon $454M AUM 46.56% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $454M AUM 28.38% 1-Year Est. Return
MI
Markowski Investments Tampa, Florida $454M AUM
MC
Miramar Capital Northbrook, Illinois $455M AUM 15.58% 1-Year Est. Return
CFO
Colony Family Offices Charlotte, North Carolina $455M AUM 21.83% 1-Year Est. Return
IIA
Integral Investment Advisors Turlock, California $454M AUM 21.42% 1-Year Est. Return

Lisanti Capital Growth's Q2 2020 Portfolio in Review

As of Q2 2020, Lisanti Capital Growth held 156 positions worth $491M, up 62% from $303M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth deployed $45.5M of net new capital in Q2 2020, opening 44 new positions and adding to 44 existing holdings. Its largest new stake was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was FIVE9, an estimated $9.22M trimmed.

  • Lisanti Capital Growth's largest Q2 2020 buy was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
  • Lisanti Capital Growth added most to Patrick Industries in Q2 2020, an estimated $4.65M increase.
  • Lisanti Capital Growth's biggest Q2 2020 reduction was FIVE9, cutting an estimated $9.22M.
  • Lisanti Capital Growth fully exited FTI Consulting in Q2 2020, selling an estimated $6.26M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $491M portfolio in Q2 2020.
  • Lisanti Capital Growth opened 44 new positions and closed 39 in Q2 2020.
  • Lisanti Capital Growth's portfolio value rose 62% quarter-over-quarter to $491M.

Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.